ICE/ENDO

Patients with osteoporosis got some good news at a recent conference when the results of a study showed that taking the drug denosumab can help increase bone density and keep their rate of fractures at a low level.

A new pill could be the next tool in a patient's fight to lose weight, according to a recent study.

Obese and overweight patients who were treated with the drug liraglutide experienced significant weight loss and were less likely to develop type 2 diabetes than patients who received placebo.

A drug which has already been approved for patients with diabetes could have more benefits for people at risk of having heart disease, according a recent study.

A recent study of patients who underwent bariatric surgery showed that even while their weight settled following their procedure their bone loss continued even two years after the operation.

An experimental, first-in-class drug that affects the gut microbiota has been shown to improve glucose tolerance and insulin sensitivity in adults with prediabetes.

A new factor in sleep and sleep apnea among obese and overweight men was introduced by researchers at a recent conference, pointing to the man's testosterone levels as helping determine sleep quality.

Intestinal bacteria levels may be a good marker for determining risk of type 2 diabetes and obesity.

The brains of hyperglycemic patients with Type 1 diabetes produce elevated levels of the neurotransmitter glutamate, which may increase their risk of depression.

Treatment for 12 weeks with empagliflozin led to significant reductions in HbA1c levels and blood pressure compared to placebo.